In conclusion, our data demonstrated that increased VEGF expression is a crucial mechanism underlying the proangiogenic activity of the HCV core protein in HCC cells, and AP-1 activation contributes to the increased VEGF expression. The gene discussed is FOS; the disease is hepatocellular carcinoma.